NCT07383441 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07383441
Title	Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
Recruitment	Recruiting
Gender	both
Phase	Phase III
Variant Requirements	No
Sponsors	SWOG Cancer Research Network
Indications	renal cell carcinoma
Therapies	Axitinib + Pembrolizumab Lenvatinib + Pembrolizumab Ipilimumab + Nivolumab Axitinib + CBM588 + Pembrolizumab CBM588 + Lenvatinib + Pembrolizumab CBM588 + Ipilimumab + Nivolumab Cabozantinib + Nivolumab Cabozantinib + CBM588 + Nivolumab
Age Groups:	senior \| adult
Covered Countries	USA

NCT07383441
Clinical Trial Detail